Addition of clinical research and strategic partnership teams marks another milestone for Qbtech in North America, bolstering the company’s regional capabilities and footprint HOUSTON, June 02, 2025-- ...
A digital test that will help to provide a faster diagnosis for people with attention deficit hyperactivity disorder (ADHD) should be used by the NHS, according to draft guidance from NICE. The QbTest ...
LONDON & HOUSTON--(BUSINESS WIRE)--The Focus ADHD program, created by objective testing provider Qbtech and the AHSN Network, received the Best Innovative Mental Health Invention at the 2022 National ...
Qbtech’s computer-based diagnostic tool QbTest has been recommended by the UK’s National Institute for Clinical Excellence (NICE) to support the diagnosis of attention deficit hyperactivity disorder ...
Industry-leading ADHD Test is the First, and Only, Digital Technology for Assessing ADHD to Achieve Endorsement The National Institute for Clinical Excellence (NICE), a UK government-funded, ...
Qbtech, the global leader in objective ADHD testing, today announced its one millionth patient milestone, amassing one of the most extensive data sets of patients tested for ADHD. Adopted by more than ...
Data presented at ADHD World Congress highlights how QbCheck supports diagnostic accuracy and individualized treatment monitoring, enabling efficient and robust care in virtual settings. News Summary: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results